Clover Health Investments (CLOV) Enterprise Value (2019 - 2026)

Clover Health Investments has reported Enterprise Value for 8 years, with the latest figure at -$197.5 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 23.34% year-over-year to -$197.5 million; the trailing twelve-month figure through Mar 2026 stood at -$197.5 million (down 23.34% YoY), and the FY2025 full-year result was -$80.1 million, up 58.84% from the prior year.
• Enterprise Value for Q1 2026 stood at -$197.5 million, down from -$80.1 million in the prior quarter.
• The five-year high for Enterprise Value was -$80.1 million in Q4 2025, with the low at -$536.7 million in Q3 2022.
• Historically, Enterprise Value has averaged -$271.6 million across 5 years, with a median of -$264.4 million in 2024.
• Annual changes were most pronounced in 2022 — Enterprise Value plunged 153.71% — and 2025, when it jumped 58.84%.
• Clover Health Investments' Enterprise Value stood at -$293.3 million in 2022, then surged by 53.94% to -$135.1 million in 2023, then plunged by 44.03% to -$194.6 million in 2024, then jumped by 58.84% to -$80.1 million in 2025, then tumbled by 146.58% to -$197.5 million in 2026.
• The last three Enterprise Value figures came in at -$197.5 million (Q1 2026), -$80.1 million (Q4 2025), and -$201.0 million (Q3 2025), per Business Quant data.